Literature DB >> 21538235

Candida albicans, a major human fungal pathogen.

Joon Kim1, Peter Sudbery.   

Abstract

Candida albicans is the most common human fungal pathogen (Beck-Sague and Jarvis, 1993). It is normally a harmless commensal organism. However, it is a opportunistic pathogen for some immunologically weak and immunocompromised people. It is responsible for painful mucosal infections such as the vaginitis in women and oral-pharangeal thrush in AIDS patients. In certain groups of vulnerable patients it causes severe, life-threatening bloodstream infections and it causes severe, life-threatening bloodstream infections and subsequent infections in the internal organs. There are various fascinating features of the C. albicans life cycle and biology that have made the pathogen the subject of extensive research, including its ability to grow in unicellular yeast, pseudohyphal, and hyphal forms (Fig. 1A); its ability to switch between different but stable phenotypic states, and the way that it retains the ability to mate but apparently loses the ability to go through meiosis to complete the sexual cycle. This research has been greatly facilitated by the derivation of the complete C. albicans genome sequence (Braun et al., 2005), the development of a variety of molecular tools for gene manipulation, and a store of underpinning knowledge of cell biology borrowed from the distantly related model yeast Saccharomyces cerevisiae (Berman and Sudbery, 2002; Noble and Johnson, 2007). This review will provide a brief overview of the importance of C. albicans as a public health issue, the experimental tools developed to study its fascinating biology, and some examples of how these have been applied.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538235     DOI: 10.1007/s12275-011-1064-7

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  39 in total

Review 1.  The distinct morphogenic states of Candida albicans.

Authors:  Peter Sudbery; Neil Gow; Judith Berman
Journal:  Trends Microbiol       Date:  2004-07       Impact factor: 17.079

Review 2.  Multilocus sequence typing of pathogenic Candida species.

Authors:  Frank C Odds; Mette D Jacobsen
Journal:  Eukaryot Cell       Date:  2008-05-02

3.  The MET3 promoter: a new tool for Candida albicans molecular genetics.

Authors:  R S Care; J Trevethick; K M Binley; P E Sudbery
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

4.  Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

Authors:  J M Hornby; E C Jensen; A D Lisec; J J Tasto; B Jahnke; R Shoemaker; P Dussault; K W Nickerson
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

5.  Evolution of alternative transcriptional circuits with identical logic.

Authors:  Annie E Tsong; Brian B Tuch; Hao Li; Alexander D Johnson
Journal:  Nature       Date:  2006-09-28       Impact factor: 49.962

Review 6.  Genetics and genomics of Candida albicans biofilm formation.

Authors:  Clarissa J Nobile; Aaron P Mitchell
Journal:  Cell Microbiol       Date:  2006-07-11       Impact factor: 3.715

7.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

8.  Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p.

Authors:  Xiao-Li Xu; Raymond Teck Ho Lee; Hao-Ming Fang; Yan-Ming Wang; Rong Li; Hao Zou; Yong Zhu; Yue Wang
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

9.  Evolution of a combinatorial transcriptional circuit: a case study in yeasts.

Authors:  Annie E Tsong; Mathew G Miller; Ryan M Raisner; Alexander D Johnson
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

10.  Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.

Authors:  Alexandra Brand; Donna M MacCallum; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Eukaryot Cell       Date:  2004-08
View more
  139 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Protective effect of fungal extracellular vesicles against murine candidiasis.

Authors:  Gabriele Vargas; Leandro Honorato; Allan Jefferson Guimarães; Marcio L Rodrigues; Flavia C G Reis; André M Vale; Anjana Ray; Joshua Daniel Nosanchuk; Leonardo Nimrichter
Journal:  Cell Microbiol       Date:  2020-07-22       Impact factor: 3.715

3.  An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.

Authors:  James R Falconer; Zimei Wu; Hugo Lau; Joanna Suen; Lucy Wang; Sarah Pottinger; Elaine Lee; Nawar Alazawi; Molly Kallesen; Derryn A Gargiulo; Simon Swift; Darren Svirskis
Journal:  Dysphagia       Date:  2014-08-24       Impact factor: 3.438

Review 4.  Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.

Authors:  Moses Madende; Jacobus Albertyn; Olihile Sebolai; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2019-09-25       Impact factor: 3.402

5.  Ribosomal protein S6 phosphorylation is controlled by TOR and modulated by PKA in Candida albicans.

Authors:  Tahmeena Chowdhury; Julia R Köhler
Journal:  Mol Microbiol       Date:  2015-08-22       Impact factor: 3.501

6.  Enhancement of anti-candidal activity of endophytic fungus Phomopsis sp. ED2, isolated from Orthosiphon stamineus Benth, by incorporation of host plant extract in culture medium.

Authors:  Tong Woei Yenn; Chong Chai Lee; Darah Ibrahim; Latiffah Zakaria
Journal:  J Microbiol       Date:  2012-07-21       Impact factor: 3.422

7.  Efg1 and Cas5 Orchestrate Cell Wall Damage Response to Caspofungin in Candida albicans.

Authors:  Kang Xiong; Chang Su; Qiangqiang Sun; Yang Lu
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

8.  6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Jun Liao; Luning Zu; Qiuye Wu; Zhongwu Guo
Journal:  ACS Infect Dis       Date:  2015-12-30       Impact factor: 5.084

9.  An Opaque Cell-Specific Expression Program of Secreted Proteases and Transporters Allows Cell-Type Cooperation in Candida albicans.

Authors:  Matthew B Lohse; Lucas R Brenes; Naomi Ziv; Michael B Winter; Charles S Craik; Alexander D Johnson
Journal:  Genetics       Date:  2020-08-24       Impact factor: 4.562

10.  Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans.

Authors:  Allia K Lindsay; Aurélie Deveau; Amy E Piispanen; Deborah A Hogan
Journal:  Eukaryot Cell       Date:  2012-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.